
Richard E. Chilcot
Examiner (ID: 8774, Phone: (571)272-6777 , Office: P/2916 )
| Most Active Art Unit | 2916 |
| Art Unit(s) | 1804, 2167, 2855, 2616, 3621, 3635, 3627, 3504, 2916, 2899, 2214, 3634, 2910 |
| Total Applications | 3224 |
| Issued Applications | 2808 |
| Pending Applications | 24 |
| Abandoned Applications | 392 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6249490
[patent_doc_number] => 20100137434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 12/583598
[patent_app_country] => US
[patent_app_date] => 2009-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14503
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137434.pdf
[firstpage_image] =>[orig_patent_app_number] => 12583598
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/583598 | Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer | Aug 20, 2009 | Issued |
Array
(
[id] => 6374762
[patent_doc_number] => 20100075950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-25
[patent_title] => 'PHENYLPROPANONE MODULATORS OF DOPAMINE RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/544194
[patent_app_country] => US
[patent_app_date] => 2009-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11495
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20100075950.pdf
[firstpage_image] =>[orig_patent_app_number] => 12544194
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/544194 | PHENYLPROPANONE MODULATORS OF DOPAMINE RECEPTOR | Aug 18, 2009 | Abandoned |
Array
(
[id] => 5398335
[patent_doc_number] => 20090318398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/543541
[patent_app_country] => US
[patent_app_date] => 2009-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 55472
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318398.pdf
[firstpage_image] =>[orig_patent_app_number] => 12543541
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/543541 | ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION | Aug 18, 2009 | Abandoned |
Array
(
[id] => 6637693
[patent_doc_number] => 20100035925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AN DMETHODS FOR INHIBITING HIV INFECTIVITY'
[patent_app_type] => utility
[patent_app_number] => 12/539741
[patent_app_country] => US
[patent_app_date] => 2009-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 1733
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035925.pdf
[firstpage_image] =>[orig_patent_app_number] => 12539741
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/539741 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AN DMETHODS FOR INHIBITING HIV INFECTIVITY | Aug 11, 2009 | Abandoned |
Array
(
[id] => 6084301
[patent_doc_number] => 20110144156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'A3 ADENOSINE RECEPTOR ALLOSTERIC MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/059836
[patent_app_country] => US
[patent_app_date] => 2009-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15097
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20110144156.pdf
[firstpage_image] =>[orig_patent_app_number] => 13059836
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059836 | A3 ADENOSINE RECEPTOR ALLOSTERIC MODULATORS | Aug 11, 2009 | Abandoned |
Array
(
[id] => 5490868
[patent_doc_number] => 20090291939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'Treating Alcohol And Or Substance Abuse By Antagonizing Alpha 2 Adrenergic Receptors With Weak Dopamine Blocking'
[patent_app_type] => utility
[patent_app_number] => 12/536143
[patent_app_country] => US
[patent_app_date] => 2009-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4981
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291939.pdf
[firstpage_image] =>[orig_patent_app_number] => 12536143
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/536143 | Treating Alcohol And Or Substance Abuse By Antagonizing Alpha 2 Adrenergic Receptors With Weak Dopamine Blocking | Aug 4, 2009 | Abandoned |
Array
(
[id] => 7490206
[patent_doc_number] => 20110237538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND OTHER PROTEOSTATIC DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/057654
[patent_app_country] => US
[patent_app_date] => 2009-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49931
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237538.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057654
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057654 | TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND OTHER PROTEOSTATIC DISEASES | Aug 3, 2009 | Abandoned |
Array
(
[id] => 9140340
[patent_doc_number] => 08580801
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'Phosphodiesterase inhibitor treatment'
[patent_app_type] => utility
[patent_app_number] => 12/508530
[patent_app_country] => US
[patent_app_date] => 2009-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 21912
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12508530
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/508530 | Phosphodiesterase inhibitor treatment | Jul 22, 2009 | Issued |
Array
(
[id] => 4486511
[patent_doc_number] => 07884093
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-08
[patent_title] => 'Progesterone for the treatment or prevention of spontaneous preterm birth'
[patent_app_type] => utility
[patent_app_number] => 12/497879
[patent_app_country] => US
[patent_app_date] => 2009-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 23
[patent_no_of_words] => 10801
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/884/07884093.pdf
[firstpage_image] =>[orig_patent_app_number] => 12497879
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/497879 | Progesterone for the treatment or prevention of spontaneous preterm birth | Jul 5, 2009 | Issued |
Array
(
[id] => 6163379
[patent_doc_number] => 20110160256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'INHIBITORS OF AKT ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/000238
[patent_app_country] => US
[patent_app_date] => 2009-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14214
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160256.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000238
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000238 | INHIBITORS OF AKT ACTIVITY | Jun 23, 2009 | Abandoned |
Array
(
[id] => 6163378
[patent_doc_number] => 20110160255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'INHIBITORS OF AKT ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/000232
[patent_app_country] => US
[patent_app_date] => 2009-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13898
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160255.pdf
[firstpage_image] =>[orig_patent_app_number] => 13000232
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/000232 | INHIBITORS OF AKT ACTIVITY | Jun 23, 2009 | Abandoned |
Array
(
[id] => 5959608
[patent_doc_number] => 20110183995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'ELTOPRAZINE FOR SUPPRESSION OF L-DOPA INDUCED DYSKINESIAS'
[patent_app_type] => utility
[patent_app_number] => 13/001058
[patent_app_country] => US
[patent_app_date] => 2009-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5530
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20110183995.pdf
[firstpage_image] =>[orig_patent_app_number] => 13001058
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/001058 | ELTOPRAZINE FOR SUPPRESSION OF L-DOPA INDUCED DYSKINESIAS | Jun 22, 2009 | Abandoned |
Array
(
[id] => 9250452
[patent_doc_number] => 08614231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-24
[patent_title] => 'Immunosuppressor based on the blockage of TCR-Nck interaction'
[patent_app_type] => utility
[patent_app_number] => 13/001914
[patent_app_country] => US
[patent_app_date] => 2009-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 4065
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13001914
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/001914 | Immunosuppressor based on the blockage of TCR-Nck interaction | Jun 17, 2009 | Issued |
Array
(
[id] => 8140837
[patent_doc_number] => 20120094974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'SMOOTHENED RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 12/737044
[patent_app_country] => US
[patent_app_date] => 2009-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 2200
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20120094974.pdf
[firstpage_image] =>[orig_patent_app_number] => 12737044
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/737044 | SMOOTHENED RECEPTOR MODULATORS | Jun 15, 2009 | Abandoned |
Array
(
[id] => 5570287
[patent_doc_number] => 20090253665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'METHOD OF TREATMENT OF DISEASE USING AN ADENOSINE A1 RECEPTOR ANTAGONIST AND AN ALDOSTERONE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 12/485797
[patent_app_country] => US
[patent_app_date] => 2009-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4507
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253665.pdf
[firstpage_image] =>[orig_patent_app_number] => 12485797
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/485797 | METHOD OF TREATMENT OF DISEASE USING AN ADENOSINE A1 RECEPTOR ANTAGONIST AND AN ALDOSTERONE INHIBITOR | Jun 15, 2009 | Abandoned |
Array
(
[id] => 6186769
[patent_doc_number] => 20110124727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-26
[patent_title] => 'Oxybuprocaine-Containing Analgesic/Antipruritic External Preparation'
[patent_app_type] => utility
[patent_app_number] => 12/999195
[patent_app_country] => US
[patent_app_date] => 2009-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3477
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20110124727.pdf
[firstpage_image] =>[orig_patent_app_number] => 12999195
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/999195 | Oxybuprocaine-Containing Analgesic/Antipruritic External Preparation | Jun 11, 2009 | Abandoned |
Array
(
[id] => 6039497
[patent_doc_number] => 20110092546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'SUBSTITUTED BENZIMIDAZOLES FOR NEUROFIBROMATOSIS'
[patent_app_type] => utility
[patent_app_number] => 12/997770
[patent_app_country] => US
[patent_app_date] => 2009-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9342
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20110092546.pdf
[firstpage_image] =>[orig_patent_app_number] => 12997770
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/997770 | SUBSTITUTED BENZIMIDAZOLES FOR NEUROFIBROMATOSIS | Jun 10, 2009 | Abandoned |
Array
(
[id] => 6048785
[patent_doc_number] => 20110207793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => '1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF SLEEP DISORDERS.'
[patent_app_type] => utility
[patent_app_number] => 12/737092
[patent_app_country] => US
[patent_app_date] => 2009-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10367
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207793.pdf
[firstpage_image] =>[orig_patent_app_number] => 12737092
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/737092 | 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF SLEEP DISORDERS. | Jun 9, 2009 | Abandoned |
Array
(
[id] => 5465815
[patent_doc_number] => 20090326015
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'COMPOUNDS WITH EMBEDDED BENZOPYRAN MOTIF FOR CORE STRUCTURES AND PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/481137
[patent_app_country] => US
[patent_app_date] => 2009-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17482
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0326/20090326015.pdf
[firstpage_image] =>[orig_patent_app_number] => 12481137
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/481137 | Compounds with embedded benzopyran motif for core structures and preparation method thereof | Jun 8, 2009 | Issued |
Array
(
[id] => 5404469
[patent_doc_number] => 20090239783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'SYNERGISTIC EFFECTS OF COMBINED ADMINISTRATION OF MIRTAZAPINE AND A STIMULANT COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/479340
[patent_app_country] => US
[patent_app_date] => 2009-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4924
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239783.pdf
[firstpage_image] =>[orig_patent_app_number] => 12479340
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/479340 | SYNERGISTIC EFFECTS OF COMBINED ADMINISTRATION OF MIRTAZAPINE AND A STIMULANT COMPOUND | Jun 4, 2009 | Abandoned |